The Centre for Cellular and Molecular Biology (CCMB) has established stable cultures of COVID-19 (SARS-CoV-2) from the samples of the patients.
CCMB Virologists isolated infectious viruses from several isolates.
The ability to culture the virus in the lab will enable the virologists at CCMB to work towards the drug testing and vaccine development to fight COVID-19.
If a large amount of virus is cultured and inactivated, it can be used as an inactivated virus vaccine.
Once the inactivated virus is injected, the human immune system will start triggering the production of germ-specific antibodies.